TT
Tinos Therapeutics, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$2.3Msold at filing
Total offering$4M$1.8M still open
Investors in the raise3count reported to the SEC
FiledApr 17, 2026first sale Sep 4, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David KarambiziExecutive Officer, Director
Anastasios PolimenakosDirector
Nikolaos TapinosExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.